News
Sarepta Therapeutics’ Duchenne therapy faces ‘arduous’ path back to market, senior FDA official says
Sarepta Therapeutics faces an "arduous path” to try to get its gene therapy for Duchenne muscular dystrophy back onto the market, a senior FDA official told STAT.
Sarepta will halt all shipments of Elevidys, its drug for Duchenne muscular dystrophy patients, by Tuesday evening.
The FDA on Tuesday rejected a skin therapy from Replimune Group, suggesting a hardened stance on drug approvals under new agency officials ...
Just how many employees is Sarepta Therapeutics laying off? And why did the FDA reject Ultragenyx's rare disease drug over ...
The FDA will request Sarepta Therapeutics stop all shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy, ...
Sarepta Therapeutics announced it has laid off more than one-third of its workforce, a drastic cost-cutting move following ...
Sarepta Therapeutics appears to have right-sized itself after laying off over a third of its staff, announcing a significant ...
Out with major season, in with playoff season. The ramp-up to the FedExCup Playoffs begins Thursday with the 3M Open.
Coverage of the second round (as well as the first) is on Golf Channel from 4-7 p.m. ET. Here are the tee times and groupings ...
2h
Golf Digest on MSN2025 3M Open tee times, TV coverage, viewer's guideVegas won last year’s 3M Open with a final-hole birdie to best Max Greyserman by one stroke. It was Vegas’ first win in seven ...
Adam Bernstein Washington, D.C. Obituary editor Adam Bernstein left The Washington Post in July 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results